Catalyst Wire Dossier Catalyst Wire Dossier

C-Trelin

unknown · HLB Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C-Trelin, covering 2023-07-24 to 2023-07-24. Get the full timeline:

Most recent: Clinical Trial Update: C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration [Phase 4]

See pricing